MyFinsight
Home
Blog
About
Contact
Inventories
$1,890K
Cash and cash
equivalents
$1,491K
Prepaid and other
current assets
$1,227K
Restricted cash and cash
equivalents
$888K
Trade accounts
receivable, net
$560K
Property and equipment,
gross
$535K
Total current assets
$6,056K
Intangible asset, net (note
7)
$778K
Property and equipment,
net
$416K
Operating lease
right-of-use assets
$150K
Other noncurrent
assets
$42K
Less accumulated
depreciation
$119K
Total assets
$7,442K
Accumulated deficit
-$902,875K
Accumulated other
comprehensive loss
-$6,643K
Total liabilities,
convertible and redeemable...
$7,442K
Total stockholders
deficit
-$77,630K
Additional paid-in capital
$831,875K
Common stock, 0.0001
par value...
$13K
Total liabilities
$80,154K
Convertible and redeemable
preferred stock
$4,918K
Total current
liabilities
$78,752K
Contingent liabilities -
noncurrent (note 7)
$1,375K
Operating lease
liabilities noncurrent
$27K
Convertible notes (note
4)-Adjuvant Notes
$33,384K
Convertible notes (note
4)-Baker Bros Notes
$18,080K
Accounts payable
$12,003K
Other current
liabilities
$10,231K
Accrued compensation
$1,495K
Accrued expenses
$1,205K
Derivative liabilities
$1,168K
Convertible notes (note
4)-Related Party
$843K
Contingent liabilities -
current (note 7)
$220K
Operating lease
liabilities current
$123K
Back
Back
Balance Sheet
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)
source: myfinsight.com